Natural pharmaceutical composition for reducing uric acid

A natural medicine and uric acid-lowering technology, applied in drug combinations, pharmaceutical formulas, plant raw materials, etc., can solve problems such as cardiovascular and cerebrovascular injuries, obvious side effects, and uremia

CN113384665APending Publication Date: 2021-09-14重庆森康道生命健康研究院有限公司
3 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2021-09-14
Patent Text Reader

Abstract

The invention relates to a natural pharmaceutical composition for reducing uric acid. The natural pharmaceutical composition specifically comprises the following components of a Chinese wolfberry extract, a radix puerariae extract, a bighead atractylodes rhizome extract, an American ginseng extract, a pseudo-ginseng extract, a cistanche extract, a plantain herb extract, a rhodiola rosea extract and a coix seed extract. The natural pharmaceutical composition can quickly and safely reduce the concentration of blood uric acid, prevent gout and relieve uncomfortable symptoms in the gout attack period; the kidney function is protected, uremia caused by hyperuricemia and reversion of uremia early-stage symptoms (the creatinine value is smaller than 600) are prevented.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the field of uric acid medicines, in particular to a combination of natural medicines for reducing uric acid. Background technique

[0002] Hyperuricemia (HUA) refers to a heterogeneous disease caused by purine metabolism disorder and / or uric acid excretion disorder, which is mainly characterized by elevated blood uric acid. In recent years, with the improvement of people's living standards and changes in dietary structure, the prevalence of hyperuricemia in my country has a very obvious upward trend.

[0003] At present, domestic and foreign uric acid-lowering products are mainly western medicines. The main drugs on the market for the treatment of hyperuricemia include: febuxostat, probesulfone, benzbromarone, allopurinol, and colchicine. Among them, febuxostat and allopurinol are xanthine oxidase inhibitors, which reduce the production of uric acid in the body to achieve the purpose of lowering uric acid. The side effect is ...

Examples

Embodiment Construction

[0009] The following preferred embodiments of the present invention are described in detail, so that the advantages and features of the present invention can be more easily understood by those skilled in the art, so that the protection scope of the present invention can be defined more clearly.

[0010] A natural drug combination for lowering uric acid, the specific components are wolfberry extract, kudzu root extract, Atractylodes macrocephala extract, American ginseng extract, Panax notoginseng extract, Cistanche deserticola extract, plantain extract, rhodiola rosea extract, coix seed Extract. Wherein the wolfberry extract, Pueraria root extract, Atractylodes macrocephala extract, American ginseng extract, Panax notoginseng extract, Cistanche deserticola extract, Plantago extract, Rhodiola rosea extract, barley extract and calamus extract are according to the mass ratio of 5-10:1-2:1-2:1:1-5:2-6:5-10:1-2:1:0.5.

[0011] After being used by more than 30 patients whose blood ...